English | Español

Ohio State Health & Discovery
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Ohio State clinic explores causes and support for cognitive decline in older adults
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

HIPEC treatment combines surgery and heated chemotherapy for advanced abdominal cancers
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Therapy dog program at Ohio State Wexner Medical Center supports staff wellness
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Experts caution against extreme health-maxxing trends promoted on social media platforms
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Robotic knee replacement enables Ohio State physician to return to patient care
+ Pharmaceuticals
Patient Daily | Jul 24, 2026

Bone marrow plays key role in blood cell production and health, experts say
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Causes, symptoms, and treatment options for psychosis in young adults discussed
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Melatonin supplements not recommended for chronic insomnia, experts say

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'